(Q38480667)

3 September 2017

Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma (English)

1 reference

3 September 2017

Bland KI

1

1 reference

3 September 2017

Konstadoulakis MM

series ordinal

2

1 reference

3 September 2017

Vezeridis MP

series ordinal

3

1 reference

3 September 2017

Wanebo HJ

series ordinal

4

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 June 1995

1 reference

3 September 2017

1 reference

3 September 2017

221

1 reference

3 September 2017

706-18; discussion 718-20

1 reference

3 September 2017

6

1 reference

The prognostic value of estrogen and progesterone receptors in female breast cancer. A single center study.

3 September 2017

1 reference

12 December 2020

Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.

1 reference

12 December 2020

Cathepsin D and prognosis in breast cancer

1 reference

12 December 2020

Increased expression of mutant forms of p53 oncogene in primary lung cancer

1 reference

12 December 2020

Oncogenes and tumor growth factors in breast cancer. A minireview

1 reference

12 December 2020

HER-2/neu amplification predicts poor survival in node-positive breast cancer

1 reference

12 December 2020

The use of flow cytometry for the prognosis of stage II adjuvant treated breast cancer patients

1 reference

12 December 2020

p53 mutations in colorectal cancer

1 reference

12 December 2020

What would you do if this were your ... wife, sister, mother, self?

1 reference

12 December 2020

Precocious Mammary Gland Development and Milk Protein Synthesis in Transgenic Mice Ubiquitously Expressing Human Growth Hormone*

1 reference

12 December 2020

Molecular themes in oncogenesis

1 reference

12 December 2020

Fluorescence of yeast vitally stained with ethidium bromide and propidium iodide

1 reference

12 December 2020

Progesterone receptors as a prognostic factor in Stage II breast cancer

1 reference

12 December 2020

A position 12-activated H-ras oncogene in all HS578T mammary carcinosarcoma cells but not normal mammary cells of the same patient

1 reference

12 December 2020

Expression of p21 ras oncoproteins in human cancers

1 reference

12 December 2020

Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.

1 reference

12 December 2020

Prognostic significance of the expression of a ras protein with a molecular weight of 21,000 by human breast cancer.

1 reference

12 December 2020

Interinstitutional variability in DNA flow cytometric analysis of tumors. The National Cancer Institute's Flow Cytometry Network Experience

1 reference

12 December 2020

DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens

1 reference

12 December 2020

Tissue-type plasminogen activator, a new prognostic marker in breast cancer

1 reference

12 December 2020

Steroid receptors and other prognostic factors in primary breast cancer

1 reference

12 December 2020

Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis

1 reference

12 December 2020

Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06

1 reference

12 December 2020

HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer

1 reference

12 December 2020

Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry

1 reference

12 December 2020

HER-2/neu oncogene protein and prognosis in breast cancer

1 reference

12 December 2020

Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years

1 reference

12 December 2020

Proto-oncogene amplification and human breast tumor phenotype

1 reference

12 December 2020

Mutations in human breast cancer: an overview

1 reference

12 December 2020

Oncogenes and signal transduction

1 reference

12 December 2020

c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes

1 reference

12 December 2020

The long term prognostic significance of c-erbB-2 in primary breast cancer

1 reference

12 December 2020

c-erbB-2 andras expression levels in breast cancer are correlated and show a co-operative association with unfavorable clinical outcome

1 reference

12 December 2020

Identification of p53 gene mutations in bladder cancers and urine samples

1 reference

12 December 2020

H-ras induced transformation of mammary epithelium is favoured by increased oncogene expression or by inhibition of mammary regression.

1 reference

12 December 2020

p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study

1 reference

12 December 2020

Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis

1 reference

12 December 2020

p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters

1 reference

12 December 2020

Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group

1 reference

12 December 2020

The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast

1 reference

12 December 2020

Progress in molecular biology of breast cancer

1 reference

12 December 2020

Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?

1 reference

12 December 2020

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

1 reference

12 December 2020

Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up

1 reference

12 December 2020

Prognostic factors in breast cancer

1 reference

12 December 2020

Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients

1 reference

12 December 2020

1 reference

12 December 2020

Wild-type p53 is a cell cycle checkpoint determinant following irradiation

1 reference

12 December 2020

Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

1 reference

12 December 2020

Retinoblastoma and p53 gene expression related to relapse and survival in human breast cancer: an immunohistochemical study

1 reference

12 December 2020

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer

1 reference

12 December 2020

c-myc oncogene expression in estrogen-dependent and -independent breast cancer

1 reference

12 December 2020

The lifetime risk of developing breast cancer

1 reference

12 December 2020

p53 as an independent prognostic marker in lymph node-negative breast cancer patients

1 reference

12 December 2020

p53 protein expression in breast cancer as related to histopathological characteristics and prognosis

1 reference

12 December 2020

Tumor markers for breast cancer

1 reference

12 December 2020

The genetics of breast cancer.

1 reference

12 December 2020

p53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment

1 reference

12 December 2020

Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer

1 reference

12 December 2020

10.1097/00000658-199506000-00010

Identifiers

DOI

1 reference

3 September 2017

1 reference